Tags: Drug.
Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer. The antibody itself tacatuzumab is conjugated with tetraxetan a chelator for yttrium-90 a radioisotope which destroys the tumour cells.
Loading...
This page contains content from the copyrighted Wikipedia article "Yttrium (90Y) tacatuzumab tetraxetan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.